A Pilot Study Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia Post-RYGB
Phase of Trial: Phase II
Latest Information Update: 10 Nov 2017
At a glance
- Drugs Exenatide (Primary)
- Indications Hypoglycaemia
- Focus Therapeutic Use
- 01 Nov 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Apr 2018.
- 11 Oct 2016 Status changed from not yet recruiting to recruiting.
- 23 Feb 2016 New trial record